iseek Communications has committed to conquering cancer by participating in The Rio Tinto Ride to Conquer Cancer® (RTCC) benefiting Queensland Institute of Medical Research (QIMR). The iseek RTCC team will join thousands of other men and women in a history-making ride from August 17-18, 2013. We will take part in a two-day ride through Queensland’s scenic countryside with a night of camping. Riders will support breakthrough research and the discovery of new cancer therapies at QIMR.
With one in two Australians diagnosed with cancer in their lifetime, iseek is rallying for the cause and cycling in The Rio Tinto Ride to Conquer Cancer.
Most of us will have witnessed a family member, friend or acquaintance fight cancer. iseek is getting involved to help make a difference and improve the chances of surviving cancer for future generations. And until a cure is found, the ride will assist QIMR with the research to improve the current treatments for cancer patients and to lessen the devastating impact it has on patients and their loved ones.
For real impact, iseek Communications has set a combined fundraising goal of $10,000. To help iseek reach this goal, visit our page to make a donation online, or call 1-300-11-RIDE.
This is the third annual Rio Tinto Ride to Conquer Cancer event in Brisbane. Riders will be supported by hundreds of volunteers and crew members who will provide meals, water and snack stops, gear transport, portable restrooms, safety on the streets, comprehensive medical services and an overnight campsite complete with tents, massages, and hot showers. For more information on the event please go towww.conquercancer.org.au. All you need is a bike, a helmet and a little motivation!
For information about the Rio Tinto Ride to Conquer Cancer benefiting Queensland Institute of Medical Research, please contact: Kate McCabe, [email protected]
About Queensland Institute of Medical Research
Queensland Institute of Medical Research, established in 1945, is one of Australia’s largest and most successful medical research institutes. Aiming to develop better diagnostics and therapies, QIMR researchers are investigating the causes of more than 13 cancers including skin, prostate, colorectal, breast, ovarian, lung and lymphoma.